SurgOnc Today®

Tumor Infiltrating Lymphocyte (TIL) Therapies in Melanoma, How's It Going and What Is Next?

28 min · 4 de jun de 2026
Portada del episodio Tumor Infiltrating Lymphocyte (TIL) Therapies in Melanoma, How's It Going and What Is Next?

Descripción

On this episode of SurgOnc Today, Dr. Amanda Kirane and Dr. Allison Betof discuss the clinical application of TIL therapy for melanoma patients, including the comprehensive care and teamwork required. They also discuss lessons learned and newer clinical trials optimizing the therapy.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de SurgOnc Today®!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

100 episodios

episode Securing Funding for Pilot Clinical Trials artwork

Securing Funding for Pilot Clinical Trials

In this episode of SurgOnc Today, Dr. Christina Angeles, surgical oncologist and Chair of the SSO Research Committee, sits down with two experienced surgical investigators, Dr. Andrew Lowy and Dr. Craig Slingluff, to discuss one of the most challenging steps in advancing surgical research: securing funding for pilot clinical trials. Drawing from their real-world experience designing and running surgical trials, our guests share practical strategies for identifying funding sources, building a competitive application, and navigating setbacks along the way. Whether you are a junior faculty member with your first research idea or a mid-career surgeon looking to expand your trials program, this episode delivers actionable advice to help you turn your clinical observations into funded research.

11 de jun de 202633 min
episode SSO Education Series—From Trials to Practice: Key Breast Cancer Insights from SSO 2026 artwork

SSO Education Series—From Trials to Practice: Key Breast Cancer Insights from SSO 2026

In this episode of SurgOnc Today, Drs. Kelly Hewitt and Austin Williams review key breast cancer presentations from the 2026 Society of Surgical Oncology Annual Meeting. They discuss real-world implementation of SOUND and INSEMA, evolving approaches to axillary management in the neoadjuvant setting, and emerging data on omission of axillary surgery. Additional highlights include outcomes with partial breast irradiation in the setting of variable endocrine therapy adherence and contemporary management of rare breast malignancies such as angiosarcoma. Together, they explore how these findings are shaping multidisciplinary decision-making and the continued evolution of surgical de-escalation in breast cancer care.

21 de may de 202621 min